Search

everythinglearnresearchcommunity

for

Search:↓

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Platelet-rich plasma therapy could be an effective treatment for melasma with minimal side effects.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Androgens can cause hair growth in some areas but hair loss on the scalp.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Women with acne have lower levels of a specific hormone marker than women without acne.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Eating less and exercising more, with personalized diet plans and realistic goals, can lead to weight loss and better health, but more research is needed for long-term success.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.